Markets:

Overview

News

Currencies

International

Treasuries

Zoetis (NY:ZTS)

127.42 +0.69 (+0.54%)

Official Closing Price Updated: 7:00 PM EST, Feb 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Zoetis

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

USDA Unveils $100 Million 'Grand Challenge' to Thwart Flesh-Eating Screwworm as Threat Reaches U.S. Border

February 05, 2026

In a decisive move to protect the nation’s multi-billion dollar livestock industry, U.S. Secretary of Agriculture Brooke Rollins announced today, February 5, 2026, the launch of a $100 million "New...

Via MarketMinute

Topics Death Economy

1 Cash-Producing Stock on Our Watchlist and 2 We Ignore

February 01, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

Zoetis Inc. (NYSE:ZTS): A Dependable Dividend Stock Built on Financial Strength ↗

January 31, 2026

Via Chartmill

Zoetis Inc (NYSE:ZTS) Passes Key Quality Investing Screen ↗

January 24, 2026

Via Chartmill

2 Healthcare Stocks Poised for a Comeback in 2026 ↗

January 22, 2026

Don't wait too long to press the buy button on these comeback stories.

Via The Motley Fool

ZOETIS INC (NYSE:ZTS) Stands Out as a Durable Dividend Stock for Income Investors ↗

January 06, 2026

Via Chartmill

This Could Be One of the Best Healthcare Stock Buying Opportunities I've Seen in Years ↗

January 22, 2026

Trading at a once-in-a-decade low valuation, this leading animal healthcare stock deserves a long look from investors.

Via The Motley Fool

Q3 Earnings Roundup: Zoetis (NYSE:ZTS) And The Rest Of The Branded Pharmaceuticals Segment

January 20, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how branded pharmaceuticals stocks fared in Q3, starting with...

Via StockStory

Topics Artificial Intelligence Intellectual Property

2 of Wall Street’s Favorite Stocks with Solid Fundamentals and 1 Facing Challenges

January 18, 2026

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...

Via StockStory

Topics Artificial Intelligence Intellectual Property

1 Profitable Stock with Solid Fundamentals and 2 We Brush Off

January 15, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

Topics Bankruptcy

Neogen Shares Skyrocket as Q2 Earnings Beat Signals Turning Point in 3M Integration Strategy

January 08, 2026

LANSING, MI – Shares of Neogen Corporation (NASDAQ: NEOG) experienced a dramatic surge in early trading today, climbing nearly 29% after the food and animal safety leader reported second-quarter fiscal...

Via MarketMinute

Topics Earnings Economy

The Paws-Solidation Era: How 2025 Became the Record-Breaking Year for Pet Care M&A

January 07, 2026

As 2025 comes to a close, the financial landscape of the pet care industry has been fundamentally reshaped by a tidal wave of mergers and acquisitions. What began as a post-pandemic stabilization...

Via MarketMinute

Topics Artificial Intelligence Economy

2 Safe-and-Steady Stocks with Competitive Advantages and 1 We Turn Down

January 06, 2026

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Via StockStory

2 Beaten-Down Stocks That Could Bounce Back in 2026 ↗

December 31, 2025

It's not time to give up on these companies yet.

Via The Motley Fool

Prescription for Growth: Why Zoetis and Viatris are Defining Healthcare’s New Winners in 2025

December 24, 2025

As the curtain closes on 2025, the healthcare sector has emerged as a landscape of stark contrasts. While traditional pharmaceutical giants have grappled with the implementation of the Medicare Part D...

Via MarketMinute

Topics Bonds Earnings World Trade

Regulatory Roadblock: ImmuCell Pivots to Core Growth After FDA Rejects Mastitis Treatment

December 24, 2025

In a significant strategic shift that marks the end of a multi-year regulatory odyssey, ImmuCell Corporation (Nasdaq: ICCC) announced late yesterday, December 23, 2025, that it has received another...

Via MarketMinute

Got $5,000? These 3 Growth Stocks Are Trading Near Their Lows. ↗

December 19, 2025

Don't overlook these potential bargain buys -- they may not stay down for long.

Via The Motley Fool

Topics Death

These 2 Healthcare Stocks Just Declared Dividend Raises ↗

December 17, 2025

The healthcare industry has never been a great source of dividends -- that alone makes these companies exceptional.

Via The Motley Fool

Topics Intellectual Property

Discover which S&P500 stocks are making waves on Tuesday. ↗

December 16, 2025

Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

These S&P500 stocks are moving in today's session ↗

December 16, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

3 Cash-Producing Stocks with Exciting Potential

December 07, 2025

Free cash flow is one of the most reliable indicators of financial durability. These businesses not only generate cash but reinvest intelligently to sustain momentum.

Via StockStory

Zoetis Inc (NYSE:ZTS) Passes the Caviar Cruise Screen for Quality Investing ↗

December 05, 2025

Zoetis exemplifies quality investing with durable competitive strengths, high returns on capital, strong cash flow, and a solid balance sheet.

Via Chartmill

These S&P500 stocks are moving in today's session ↗

December 02, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Which S&P500 stocks are gapping on Tuesday? ↗

December 02, 2025

Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Tuesday. Discover the gap up and gap down stocks in the S&P500 index.

Via Chartmill

1 Oversold Stock Primed to Rebound and 2 We Find Risky

December 01, 2025

Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value...

Via StockStory

Topics Supply Chain

2 Stocks to Buy Near Their 52-Week Lows ↗

December 01, 2025

These companies' prospects are better than recent performances may suggest.

Via The Motley Fool

Topics Artificial Intelligence World Trade

Zoetis and Surgery Partners Shares Are Soaring, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Earnings Economy

U.S. Agriculture Braces for a Tight 2025: The 'Cost-Price Squeeze' Threatens Farm Profitability

November 20, 2025

The American agricultural sector is facing a formidable challenge in 2025, as a relentless "cost-price squeeze" threatens to significantly erode farm profitability. This economic vise is tightening...

Via MarketMinute

Topics Climate Change Economy Energy

A Look Into Zoetis Inc's Price Over Earnings ↗

November 20, 2025

Via Benzinga

Zoetis (ZTS): Buy, Sell, or Hold Post Q3 Earnings?

November 19, 2025

Zoetis’s stock price has taken a beating over the past six months, shedding 28.6% of its value and falling to a new 52-week low of $116.88 per share. This was partly due to its softer quarterly results...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.